Tilray, Inc.’s (NASDAQ: TLRY) Status as Global Pioneer in Cannabis Production, Distribution Reinforced by Earnings, Growth

First medical cannabis producer in North America to meet rigorous standards of GMP certification, supplying cannabis flower and extracts Canadian federally-licensed cannabis cultivator, processor and distributor Q2 2018 revenue increased to $9.7 million, up 95.2 percent over second quarter of 2017 Multinational distribution network makes Tilray medical cannabis available to patients in 11 countries on five continents Raised $163.6 million in a successful IPO in July 2018 and $55 million from leading institutional investors prior to IPO Agreements signed to supply medical cannabis via Canadian pharmacies and recreational cannabis to adult-use consumers in seven Canadian provinces and territories Received U.S. government approval to import cannabinoid study drug to UC San Diego for clinical trial for treatment of essential tremor, a neurological disorder

Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, continues to build an international footprint in the cannabis space with a long list of “firsts” in the cannabis industry. As one of only a few cannabis companies with a U.S. stock listing, Tilray’s stock has been a favorite of investors, soaring more than 10-fold since its initial public offering in July. Tilray’s diverse management team of industry leading experts includes PhD research scientists, master horticulturalists, engineers and patient advocates, in addition to backing by billionaire investor Peter Thiel.

Tilray’s aggressive pursuit of agreements to supply premium cannabis products to not only the Canadian market, which is poised to become the first G7 country to legalize recreational cannabis nationwide in October, but to any country that has legalized cannabis. Among its most recent announcements, the company has:

Executed a non-binding letter of intent with IntelGenx Corp. to co-develop and commercialize oral film products infused with recreational and medical cannabis (http://nnw.fm/1TZGe) Received approval from the U.S. Drug Enforcement Administration (DEA) to import a medical cannabis supply drug for a clinical trial on essential tremor at the University of California San Diego Center for Medicinal Cannabis Research (http://nnw.fm/DrvY9) Regulatory permits approved for export to Germany of medical cannabis flower and full-spectrum medical cannabis oil for patient use (http://nnw.fm/12Aym) Currently supplying products for several different clinical trials in partnership with universities, hospitals and governments in Australia and Canada (http://nnw.fm/SHt5N) Established wholly owned subsidiary High Park Company to produce and distribute a broad-based portfolio of cannabis brands and products in Canada; an investment totaling $100 million that’s expected to grow the company’s Canadian workforce to more than 500 in the next several years

In Deloitte’s 2018 cannabis report (http://nnw.fm/TpE5o), the research firm frames the total cannabis market in Canada as “significant” and one that has “spurred innovation, entrepreneurship and jobs.” Canada’s medical and recreational cannabis market is expected to generate $7.17 billion in total sales in 2019.

Brendan Kennedy, president and chief executive officer of Tilray, notes the company’s strong start to 2018 and offers insight to its future plans in a second quarter earnings report to stakeholders (http://nnw.fm/0h36O).

“Tilray is well-positioned to continue to pioneer the development of the global medical cannabis market and to become a leader in the adult-use cannabis market in Canada,” Kennedy states in the report. “In the second quarter, we generated significant revenue growth as a result of our global strategy, our multinational distribution network and our commitment to research, innovation, quality and operational excellence.”

Financial highlights in the report include an increase in revenue to $9.7 million, up 95.2 percent compared to the second quarter of 2017; a 97 percent increase in total kilogram equivalents sold compared to the prior year; and an average net selling price per gram increase from $6.20 to $6.38.

Business highlights in 2018 to date show Tilray’s successful IPO and funding received from institutional investors that brought $218.6 million to the company; signed agreements to supply cannabis to adult-use consumers in seven Canadian provinces and territories and signed strategic agreements with Sandoz Canada, a division of Novartis, to collaborate on the creation and sale of co-branded and co-developed non-combustible medical cannabis products. Agreements or LOIs were also signed with Shoppers Drug Mart Inc., Canada’s largest pharmacy chain, and Pharmasave, one of Canada’s leading independent pharmacy chains, to provide Tilray products once certain legal steps have been met.

Exports to Argentina, South Africa and the United Kingdom now make Tilray products available in 11 countries on five continents. The company also launched High Park Holdings Ltd., a wholly owned subsidiary formed to serve the pending adult-use market in Canada, in addition to the launch of the CANACA brand, which celebrates the historic moment in Canada as it becomes the first G7 nation to federally legalize cannabis for adult-use.

Tilray’s company culture promotes experience, precision, research and care for its customers and clients. Its precisely formulated products are cultivated to meet exacting patient needs and come in two primary forms – extracts and dried flower. Tilray’s product line centers on active ingredients and standardized, well-defined preparations with a focus on patient safety and efficacy. The company’s clinical research program is designed to evolve current scientific understanding of the therapeutic value and risks of cannabinoid-based medicines. Tilray’s flagship production facility is located in Nanaimo, Vancouver Island, British Columbia.

For more information, visit the company’s website at www.Tilray.com

More from NetworkNewsWire

ABC Summit Offers Networking and Discussion around the Future of Blockchain Technologies ChineseInvestors.com, Inc. (CIIX) Expands North American Footprint for Chinese-Language News, CBD Product Market Blockchain World Conference at The Diplomat Beach Resort in Hollywood, Florida, to Feature Brock Pierce as Keynote Speaker

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office

Recent News

Potential privacy lapse found in Americans' 2010 census data

Feb 17, 2019

WASHINGTON — An internal team at the Census Bureau found that basic personal information collected from more than 100 million Americans during the 2010 head count could be reconstructed from obscured data, but with lots of mistakes, a top agency official disclosed Saturday. The age, gender, location, race and ethnicity for 138 million people were potentially vulnerable. So far, however, only internal hacking teams have discovered such details at possible risk, and no outside groups are known to have grabbed data intended to remain private for 72 years, chief scientist John Abowd told a scientific conference. The Census Bureau is...

Year in space put US astronaut's disease defenses on alert

Feb 17, 2019

WASHINGTON — Nearly a year in space put astronaut Scott Kelly's immune system on high alert and changed the activity of some of his genes compared to his Earth-bound identical twin, researchers said Friday. Scientists don't know if the changes were good or bad but results from a unique NASA twins study are raising new questions for doctors as the space agency aims to send people to Mars. Tests of the genetic doubles gave scientists a never-before opportunity to track details of human biology, such as how an astronaut's genes turn on and off in space differently than at home....

Love on the rocks: Penguins celebrating Valentine's Day

Feb 17, 2019

SAN FRANCISCO — Penguins made a love connection at a San Francisco aquarium. In what has become an annual Valentine's Day tradition, biologists handed out red felt hearts Tuesday to African penguins at the California Academy of Sciences. The birds grabbed the hearts in their beaks and waddled around their rocky enclosure toward their nests. Spokeswoman Kelly Mendez says it's often the male penguin who retrieves the heart and carries it back to his mate. The penguins use the felt for material in their nests, which helps reinforce the couples' bonds. The activity is part of the academy's captive breeding...

PBS' 'Finding Your Roots' looks into political leaders' past

Feb 17, 2019

ALBUQUERQUE, N.M. — Harvard scholar Henry Louis Gates, Jr., hopes this season of his popular PBS series "Finding Your Roots" helps a divided U.S. see how all Americans have unique family links and how those family histories tell the story of the country. Now in its fifth season, the series takes advantage of new advancements in genealogy and genetics to look into the history of American celebrities. In upcoming episodes Gates and his team investigate the pasts of diverse subjects like former U.S. House Speaker Paul Ryan, Rep. Tulsi Gabbard of Hawaii and "Game of Thrones" author George R. R....

The Latest: Trump signs order on artificial intelligence

Feb 17, 2019

NEW YORK — The Latest on Trump executive order on artificial intelligence (all times local): 4:15 p.m. President Donald Trump has signed an executive order directing federal agencies to prioritize research and development in artificial intelligence. The plan is called the American AI Initiative. Trump signed the directive Monday. It comes after China and other countries have pledged big investments to advance and apply AI technology in fields ranging from warfighting to health care. The White House plan doesn't include any funding details. The administration says it's up to Congress to appropriate money. The order is short on details but...

About Us

Science Buzz is a user-friendly website which concentrates on news for the Big Three: Biology, Chemistry, and Physics.

Contact us: sales@thescnbuzz.com